nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—PDE1A—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0195	0.0195	CbGpPWpGaD
Nicardipine—PDE1A—Downstream signal transduction—FRS2—nasal cavity cancer	0.0183	0.0183	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by FGFR—FRS2—nasal cavity cancer	0.0182	0.0182	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0181	0.0181	CbGpPWpGaD
Nicardipine—PDE1A—DAP12 signaling—FRS2—nasal cavity cancer	0.018	0.018	CbGpPWpGaD
Nicardipine—PDE1B—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0178	0.0178	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.017	0.017	CbGpPWpGaD
Nicardipine—PDE1A—DAP12 interactions—FRS2—nasal cavity cancer	0.017	0.017	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by EGFR—FRS2—nasal cavity cancer	0.0168	0.0168	CbGpPWpGaD
Nicardipine—PDE1B—Downstream signal transduction—FRS2—nasal cavity cancer	0.0167	0.0167	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0167	0.0167	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by FGFR—FRS2—nasal cavity cancer	0.0166	0.0166	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by PDGF—FRS2—nasal cavity cancer	0.0166	0.0166	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0166	0.0166	CbGpPWpGaD
Nicardipine—PDE1B—DAP12 signaling—FRS2—nasal cavity cancer	0.0165	0.0165	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0155	0.0155	CbGpPWpGaD
Nicardipine—PDE1B—DAP12 interactions—FRS2—nasal cavity cancer	0.0155	0.0155	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by EGFR—FRS2—nasal cavity cancer	0.0154	0.0154	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0152	0.0152	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by PDGF—FRS2—nasal cavity cancer	0.0152	0.0152	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—CXCL11—nasal cavity cancer	0.0151	0.0151	CbGpPWpGaD
Nicardipine—PDE1A—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.015	0.015	CbGpPWpGaD
Nicardipine—CHRM4—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0148	0.0148	CbGpPWpGaD
Nicardipine—PDE1B—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0137	0.0137	CbGpPWpGaD
Nicardipine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0117	0.0117	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by NGF—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Nicardipine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0113	0.0113	CbGpPWpGaD
Nicardipine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by NGF—FRS2—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Nicardipine—CHRM2—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.00983	0.00983	CbGpPWpGaD
Nicardipine—CHRM4—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00895	0.00895	CbGpPWpGaD
Nicardipine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00878	0.00878	CbGpPWpGaD
Nicardipine—CHRM5—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00857	0.00857	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00805	0.00805	CbGpPWpGaD
Nicardipine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00792	0.00792	CbGpPWpGaD
Nicardipine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0079	0.0079	CbGpPWpGaD
Nicardipine—PDE1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Nicardipine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00782	0.00782	CbGpPWpGaD
Nicardipine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0078	0.0078	CbGpPWpGaD
Nicardipine—PDE1B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00718	0.00718	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00712	0.00712	CbGpPWpGaD
Nicardipine—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00706	0.00706	CbGpPWpGaD
Nicardipine—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00683	0.00683	CbGpPWpGaD
Nicardipine—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00683	0.00683	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00669	0.00669	CbGpPWpGaD
Nicardipine—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.00663	0.00663	CbGpPWpGaD
Nicardipine—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.0066	0.0066	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—FRS2—nasal cavity cancer	0.00659	0.00659	CbGpPWpGaD
Nicardipine—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00657	0.00657	CbGpPWpGaD
Nicardipine—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.00653	0.00653	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00652	0.00652	CbGpPWpGaD
Nicardipine—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.00642	0.00642	CbGpPWpGaD
Nicardipine—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.00642	0.00642	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.00638	0.00638	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.00638	0.00638	CbGpPWpGaD
Nicardipine—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00635	0.00635	CbGpPWpGaD
Nicardipine—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00635	0.00635	CbGpPWpGaD
Nicardipine—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.00632	0.00632	CbGpPWpGaD
Nicardipine—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.00632	0.00632	CbGpPWpGaD
Nicardipine—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.00615	0.00615	CbGpPWpGaD
Nicardipine—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00615	0.00615	CbGpPWpGaD
Nicardipine—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00615	0.00615	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.00609	0.00609	CbGpPWpGaD
Nicardipine—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00604	0.00604	CbGpPWpGaD
Nicardipine—CHRM1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00603	0.00603	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—FRS2—nasal cavity cancer	0.00602	0.00602	CbGpPWpGaD
Nicardipine—CHRM3—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00601	0.00601	CbGpPWpGaD
Nicardipine—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.00601	0.00601	CbGpPWpGaD
Nicardipine—CHRM2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00595	0.00595	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00594	0.00594	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00589	0.00589	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.00589	0.00589	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00584	0.00584	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00584	0.00584	CbGpPWpGaD
Nicardipine—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00582	0.00582	CbGpPWpGaD
Nicardipine—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.00582	0.00582	CbGpPWpGaD
Nicardipine—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.00569	0.00569	CbGpPWpGaD
Nicardipine—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.0055	0.0055	CbGpPWpGaD
Nicardipine—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.0055	0.0055	CbGpPWpGaD
Nicardipine—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00545	0.00545	CbGpPWpGaD
Nicardipine—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00527	0.00527	CbGpPWpGaD
Nicardipine—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00527	0.00527	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00506	0.00506	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00484	0.00484	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00459	0.00459	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00455	0.00455	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0044	0.0044	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00421	0.00421	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.00419	0.00419	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00413	0.00413	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00405	0.00405	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00405	0.00405	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00385	0.00385	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—FRS2—nasal cavity cancer	0.00384	0.00384	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00378	0.00378	CbGpPWpGaD
Nicardipine—PDE1A—Disease—FRS2—nasal cavity cancer	0.00354	0.00354	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—FRS2—nasal cavity cancer	0.00351	0.00351	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00343	0.00343	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00341	0.00341	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0034	0.0034	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00337	0.00337	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00336	0.00336	CbGpPWpGaD
Nicardipine—PDE1B—Disease—FRS2—nasal cavity cancer	0.00324	0.00324	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0031	0.0031	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00309	0.00309	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00306	0.00306	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00305	0.00305	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CXCL11—nasal cavity cancer	0.00271	0.00271	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CXCL11—nasal cavity cancer	0.0026	0.0026	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0025	0.0025	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0025	0.0025	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00248	0.00248	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CXCL11—nasal cavity cancer	0.00244	0.00244	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00239	0.00239	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.00231	0.00231	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.00231	0.00231	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.00229	0.00229	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—FRS2—nasal cavity cancer	0.00227	0.00227	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00222	0.00222	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00222	0.00222	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00203	0.00203	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00183	0.00183	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00182	0.00182	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00181	0.00181	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.0018	0.0018	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—FRS2—nasal cavity cancer	0.0016	0.0016	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—FRS2—nasal cavity cancer	0.00153	0.00153	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00153	0.00153	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00148	0.00148	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00148	0.00148	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—FRS2—nasal cavity cancer	0.00144	0.00144	CbGpPWpGaD
Nicardipine—CALM3—Immune System—FRS2—nasal cavity cancer	0.00139	0.00139	CbGpPWpGaD
Nicardipine—CALM2—Immune System—FRS2—nasal cavity cancer	0.00135	0.00135	CbGpPWpGaD
Nicardipine—CALM1—Immune System—FRS2—nasal cavity cancer	0.00135	0.00135	CbGpPWpGaD
Nicardipine—CALM3—Disease—FRS2—nasal cavity cancer	0.00128	0.00128	CbGpPWpGaD
Nicardipine—CALM2—Disease—FRS2—nasal cavity cancer	0.00124	0.00124	CbGpPWpGaD
Nicardipine—CALM1—Disease—FRS2—nasal cavity cancer	0.00124	0.00124	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—FRS2—nasal cavity cancer	0.00119	0.00119	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00108	0.00108	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00107	0.00107	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00106	0.00106	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00106	0.00106	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.000899	0.000899	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00087	0.00087	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00087	0.00087	CbGpPWpGaD
